BioCentury
ARTICLE | Company News

Cynapsus, Sumitomo Dainippon deal

September 5, 2016 7:00 AM UTC

Sumitomo’s Sunovion Pharmaceuticals Inc. unit will acquire Cynapsus for $40.50 per share in a cash deal the companies say values Cynapsus at about $624 million. The price is a 121% premium to Cynapsus...